| Literature DB >> 31656618 |
Astrid Bacle1,2, Sorya Belaz2,3, Sophie Potin1,2, Jean-Pierre Gangneux2,3.
Abstract
Terbinafine is an antifungaldrug(inhibitor of ergosterol synthesis) known to induce skin reactions. A 58-year-old female was treated with terbinafine for onychomycosis. On the fifth day of treatment a skin rash emerged on her sun-exposed areas. Biological testing did not find any allergic signs. Other skin reactions are well known with terbinafine, but we depict here, a case of photosensitisation induced by treatment, generally unknown for this antifungal. This side effect can be prevented by medication reconciliation and pharmaceutical advice from the clinical pharmacist. © European Association of Hospital Pharmacists 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: clinical pharmacist; drug-induced photosensitivity; medication reconciliation; pharmaceutical advice; terbinafine
Year: 2018 PMID: 31656618 PMCID: PMC6788264 DOI: 10.1136/ejhpharm-2018-001683
Source DB: PubMed Journal: Eur J Hosp Pharm ISSN: 2047-9956